
ADID-CACD Syndrome: Signs, Genes and Diagnosis
Intellectual disability, distinctive facial features and heart defects together define ADID-CACD. DNA testing separates it from syndromes that look similar.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Intellectual disability, distinctive facial features and heart defects together define ADID-CACD. DNA testing separates it from syndromes that look similar.

One altered copy of a gene is enough to cause ADNSHL40, hearing impairment with no other symptoms. Results can guide hearing aids, implants and other therapies.

Hearing impairment without syndromic features defines ADNSHL 67, linked to a CEACAM16 missense variant. Not every variant has clear clinical significance.

Short stature, brachydactyly and craniofacial dysmorphism arise when DVL1 mutations disturb Wnt signaling. An early ADRS2 diagnosis opens growth therapies.

Newborn screening programs can include tests for the PKHD1L1 mutations behind ARNSHL 104, so hearing aids or cochlear implants can be considered early in life.

SNX14 mutations, inherited in a recessive pattern, sit behind the coordination, balance and speech difficulties that ARSCA20 brings on in childhood.

Part of the primary familial brain calcification group, IBGC6 is studied through genes such as SLC20A2, PDGFRB and PDGFB that testing can check before symptoms appear.

Overactive NF-κB signaling from CARD11 mutations drives B cell expansion and T cell anergy, leaving patients with recurrent infections and autoimmune problems.